BioArctic And Eisai Collaborate On Evaluating BAN2802 For Alzheimer's Disease
21/4 04:37
(RTTNews) - BioArctic AB and Eisai Co., Ltd., have agreed to collaborate on the research and evaluation of BAN2802, a potential new treatment that combines BioArctic's BrainTransporter technology with an undisclosed Alzheimer's drug candidate, BioArctic said in a statement....